Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 18, 2022

SELL
$86.26 - $119.0 $10 Million - $13.9 Million
-116,479 Closed
0 $0
Q3 2021

Nov 12, 2021

BUY
$100.17 - $126.36 $11.7 Million - $14.7 Million
116,479 New
116,479 $13 Million

Others Institutions Holding NTRA

About Natera, Inc.


  • Ticker NTRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 96,957,400
  • Market Cap $12B
  • Description
  • Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...
More about NTRA
Track This Portfolio

Track Castle Ark Alternatives, LLC Portfolio

Follow Castle Ark Alternatives, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Castle Ark Alternatives, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Castle Ark Alternatives, LLC with notifications on news.